Medford, MA, United States of America

Krista E Gipson

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 16.3

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Krista E Gipson

Introduction

Krista E Gipson is an accomplished inventor based in Medford, Massachusetts, known for her significant contributions in the field of pharmaceuticals. With a remarkable portfolio of six patents, she has demonstrated her expertise in developing innovative compounds that address critical medical issues, particularly in the realm of cancer and other proliferative diseases.

Latest Patents

Among her latest patents is the groundbreaking work on "Allosteric EGFR inhibitors and methods of use thereof." This invention pertains to a compound of Formula (I), which serves as an allosteric inhibitor of the epidermal growth factor receptor (EGFR). The patent also includes pharmaceutical compositions comprising the compound and methods for treating or preventing kinase-mediated disorders, particularly cancer and other proliferation diseases.

Another important patent is titled "Heteroaryls and uses thereof." This invention offers a compound of formula I, along with pharmaceutically acceptable salts, which acts as inhibitors of VPS34. Such compounds are instrumental in treating an array of disorders, including proliferative, inflammatory, or cardiovascular diseases.

Career Highlights

Krista Gipson has developed her prowess through valuable experiences at prestigious companies like Millennium Pharmaceuticals Limited and Takeda Pharmaceutical Company Limited. Her role in these organizations has allowed her to enhance her research and development skills, contributing to significant advancements in therapeutic solutions.

Collaborations

Throughout her career, Krista has had the privilege of collaborating with esteemed colleagues, including Courtney A Cullis and Yongbo Hu. These partnerships have fostered an environment of innovation and have propelled her research and inventions to new heights.

Conclusion

Krista E Gipson remains a leading figure in the realm of pharmaceutical innovation. Her dedication to creating groundbreaking solutions and her extensive patent portfolio reflect her unwavering commitment to enhancing healthcare through invention. Her work illustrates the profound impact inventors can have in addressing complex medical challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…